LB Pharmaceuticals Inc earnings releases LBRX

Annual Quarterly

LB Pharmaceuticals Inc last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): diluted EPS of -$1.79. It usually reports 36–42 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 11, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–42 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Nov 5, 2026
36 days after quarter end
Q3 FY2026
ended Sep 30, 2026
—
-59
-1561.0%
-1.79
-193.4%
Aug 11, 2026
42 days after quarter end
Q2 FY2026
ended Jun 30, 2026
—
-52
-1.71
May 12, 2026
42 days after quarter end
Q1 FY2026
ended Mar 31, 2026
—
-19
-0.67
Nov 6, 2025
37 days after quarter end
Q3 FY2025
ended Sep 30, 2025
—
-4
-0.61

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LBRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1691082
Former names
LB PHARMACEUTICALS INC. (until Dec 12, 2018)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.